Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases

BACKGROUND: There are concerns about a link between the ChAdOx1 nCoV-19 and Ad26.COV2.S vaccines against COVID-19 and cerebral venous thrombosis (CVT) and other thrombotic events. One key missing component of the risk-benefit analysis of using such vaccines is the risk of these severe thrombotic eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Taquet, Maxime, Husain, Masud, Geddes, John R, Luciano, Sierra, Harrison, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324974/
https://www.ncbi.nlm.nih.gov/pubmed/34368663
http://dx.doi.org/10.1016/j.eclinm.2021.101061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324974/
https://www.ncbi.nlm.nih.gov/pubmed/34368663
http://dx.doi.org/10.1016/j.eclinm.2021.101061

Ejemplares similares